BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• TCT 2017: BIOTRONIK’s Orsiro Drug-Eluting Stent Shows Low Five-Year Event Rates in BIOFLOW-II RCT and BIOFLOW-III Registry

  Data from the BIOFLOW-II randomized controlled trial was presented in a poster session by Dr. Ton Slagboom, Onze Lieve Vrouwe Gasthuis, Amsterdam, Netherlands, showing a target leisure failure (TLF) rate of 10.4 percent in the Orsiro group and 12.7 percent in the Xience2 study arm at 60 months (p=0.4728).

  November 2, 2017

   · 

  2 min read
• Scottish Equity Partners Announces Investment in Dotmatics

  The investment deal was led by SEP partners Keith Davidson and Jan Rutherford.

  November 2, 2017

   · 

  3 min read
• Business

  Cyrano Partners With Shanghai Newsummit to Develop Treatment for Loss of Smell

  Cyrano Therapeutics has established a partnership with Shanghai Newsummit Biopharma for China development of theophylline, Cyrano’s intranasal therapy to treat loss of smell.

  November 2, 2017

   · 

  1 min read
• Business

  Caladrius Biosciences to Host 2017 Third Quarter Business Update Conference Call on November 9, 2017 at 4:30 p.m. Eastern Time

  Caladrius’ management will host a conference call for the investment community beginning at 4:30 p.m. ET.

  November 2, 2017

   · 

  3 min read
• Business

  BioSig Technologies Partners With Sherpa Technology Group

  The company has hired Sherpa Technology Group as its Intellectual Property Advisor.

  November 2, 2017

   · 

  5 min read
• Business

  Smithers Avanza Invests to Support Growing Client Needs

  Smithers Avanza, a boutique contract research organization (CRO) continues to invest in the space, equipment and personnel needed to address the growing demand by clients for independent third-party.

  November 2, 2017

   · 

  2 min read
• Business

  AMAG Pharmaceuticals Announces Third Quarter 2017 Financial Results and Business Highlights

  Total GAAP revenue for the third quarter of 2017 increased to $153.7 million, 7% higher than the same period last year.

  November 2, 2017

   · 

  30 min read
• Biotech Beach

  SeaSpine Announces Limited Commercial Launch of OsteoStrand Demineralized Bone Fibers

  The first implantations were completed by Dr. Khalid Abbed, Vice Chair of Neuro Surgery and Director of Minimally Invasive Spine Surgery at Yale School of Medicine and orthopedic spine surgeon Michael W. Cluck, M.D., PhD, at the Bay Area Spine Care in San Jose, CA.

  November 2, 2017

   · 

  4 min read
• Business

  Aviragen Therapeutics Reports First Quarter of Fiscal Year 2018 Financial Results

  The Company reported a net loss of $5.3 million for the three month period ended September 30, 2017, as compared to a net loss of $10.0 million in the same quarter of the prior fiscal year.

  November 2, 2017

   · 

  11 min read
• Business

  Therapix Biosciences Third Quarter 2017 Conference Call and Webcast Scheduled for Thursday, November 9, 2017

  Therapix announced today that it will host a conference call and webcast on Thursday, November 9, 2017, to discuss results for the period ended September 30, 2017 and to provide an update on current developments with respect to its clinical programs.

  November 2, 2017

   · 

  3 min read